CN1273847A - Chinese medicine for treating dermatopathy - Google Patents
Chinese medicine for treating dermatopathy Download PDFInfo
- Publication number
- CN1273847A CN1273847A CN 99107327 CN99107327A CN1273847A CN 1273847 A CN1273847 A CN 1273847A CN 99107327 CN99107327 CN 99107327 CN 99107327 A CN99107327 A CN 99107327A CN 1273847 A CN1273847 A CN 1273847A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- medicine
- root
- salviae miltiorrhizae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A Chinese medicine for treating dermatopathy including leukoderma, skin itch and chronic eczema is prepared from 10 Chinese-medicinal materials including eclipta, fleece flower root, flavescent sophora root, arnebia root, violet sage root, etc. It has high curative effect.
Description
The present invention is the Chinese medicine that is used for the treatment of skin, is the medicine that is used for the treatment of vitiligo, skin pruritus and chronic eczema specifically, belongs to the field of Chinese medicines.
Vitiligo, skin pruritus and chronic eczema belong to the common skin disease, and these disease incidence height lack effective medicine, particularly vitiligo clinically, and the patient suffers untold misery.The inventor shows to execute in conjunction with differential diagnosis in tcm and controls according to handed down from the older generations of the family testing, and thinks that this disease is that ailment said due to cold or exposure is invaded skin, invades pore, causes stagnation of QI-blood, and hair is stolen inaccessible, due to the not flourish skin of blood, has invented the application's Chinese medicine.
The present invention provides a kind of treatment vitiligo, skin pruritus, dermopathic Chinese medicine such as chronic eczema.
Medicine of the present invention is to be made by following medium-height grass: (weight portion)
Herba Ecliptae 60-120 part Radix Polygoni Multiflori 40-80 part SEMEN ASTRAGALI COMPLANATI 40-80 part
Fructus tribuli 40-80 part Radix Sophorae Flavescentis 20-50 part Radix Arnebiae (Radix Lithospermi) 30-60 part
Radix Salviae Miltiorrhizae 20-50 part Radix Angelicae Dahuricae 40-80 part Rhizoma Paridis 20-40 part
Rhizoma Atractylodis 20-50 part
Medicine of the present invention can be prepared into conventional dose with conventional formulation technology, as tablet, powder, pill, oral liquid, capsule etc. by said ratio.
The preparation method of bolus of drug of the present invention is as follows:
Herba Ecliptae, Radix Polygoni Multiflori, husky disease Herba chenopodii, fructus tribuli, Radix Sophorae Flavescentis, Radix Arnebiae (Radix Lithospermi), Radix Salviae Miltiorrhizae, seven flavor medicine are decocted with water twice, filter, merge filtrate twice, standby.
Again the Radix Angelicae Dahuricae, Rhizoma Paridis, Rhizoma Atractylodis are ground into fine powder, cross the 100-120 mesh sieve, standby, filtrate is sucked fine powder, drying and crushing adds water pill with the honey refining, is drying to obtain.
Per 10 balls of medicine of the present invention weigh 1,8 gram, take the 10-18 grain, twice of every day at every turn.
Function: expelling wind and activating blood circulation, remove damp and clearing heat, liver and kidney tonifying.
Cure mainly: vitiligo, skin pruritus, chronic eczema etc.
Use clinical drug of the present invention to observe general property of treatment 263 routine limitation vitiligo, effect is as follows:
40 example recoveries from illness are wherein arranged, follow up a case by regular visits to 2-5 and do not recur, it is obvious to account for 15.2%, 132 routine effect, focus is dwindled, and irregular filbert pigment appears in the affected part, and white macula dwindles, the skin small particles that sporadically appears, what have obviously disappears, affected area hair, eyebrow, fine hair blackening, account for 50.19%, 56 routine patient and controlled, do not develop, also do not recover, account for 21.29%, total effective rate accounts for 86.69%, 35 examples were taken medicine about one month, and are invalid, account for 13.3%.
Embodiment
Herba Ecliptae 90 gram Radix Polygoni Multiflori 60 gram SEMEN ASTRAGALI COMPLANATIs 60 grams
Fructus tribuli 60 gram Radix Salviae Miltiorrhizae 30 gram Radix Sophorae Flavescentiss 30 grams
Radix Arnebiae (Radix Lithospermi) 45 grams
More than seven flavors decoct with water twice, 40-50 minute for the first time, 30 minutes for the second time, each amount of water did not have powder, filtered, and divided and filtrate for later use;
The Radix Angelicae Dahuricae 60 grams, Rhizoma Paridis 30 grams, Rhizoma Atractylodis 24 grams three flavor medicated powder are broken into fine powder, cross the 100-120 mesh sieve, filtrate is sucked fine powder, drying and crushing adds water pill with refined honey, is drying to obtain.
Claims (2)
1. leukodermic Chinese medicine of treatment is characterized in that this medicine is with the component of the following weight parts Chinese patent medicine made of technology routinely:
Herba Ecliptae 60-120 part Radix Polygoni Multiflori 40-80 part SEMEN ASTRAGALI COMPLANATI 40-80 part
Fructus tribuli 40-80 part Radix Sophorae Flavescentis 20-50 part Radix Arnebiae (Radix Lithospermi) 30-60 part
Radix Salviae Miltiorrhizae 20-50 part Radix Angelicae Dahuricae 40-80 part Rhizoma Paridis 20-40 part
Rhizoma Atractylodis 20-50 part.
2. according to the Chinese medicine of claim 1, it is characterized in that the weight ratio of each component is:
Herba Ecliptae 90 Radixs Angelicae Dahuricae 60 Radix Polygoni Multiflori 60
SEMEN ASTRAGALI COMPLANATI 60 fructus tribulis 60 Radix Arnebiae (Radix Lithospermi)s 45
Rhizoma Paridis 30 Radix Salviae Miltiorrhizae 30 Radix Sophorae Flavescentiss 30
Rhizoma Atractylodis 24.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99107327 CN1273847A (en) | 1999-05-14 | 1999-05-14 | Chinese medicine for treating dermatopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99107327 CN1273847A (en) | 1999-05-14 | 1999-05-14 | Chinese medicine for treating dermatopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1273847A true CN1273847A (en) | 2000-11-22 |
Family
ID=5272712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 99107327 Pending CN1273847A (en) | 1999-05-14 | 1999-05-14 | Chinese medicine for treating dermatopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1273847A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100352479C (en) * | 2004-12-29 | 2007-12-05 | 韩石蕊 | Medicament for treating leucoderma and prepartion method |
| CN101204518B (en) * | 2007-12-13 | 2011-06-29 | 孙瑞龙 | Peroral Chinese traditional medicine for blood deficiency cutaneouspruritus |
| CN101361890B (en) * | 2008-09-28 | 2011-07-27 | 中国人民解放军第四军医大学 | Traditional Chinese medicine formulation for treating radioactivity skin impairment |
| CN102362950A (en) * | 2011-06-15 | 2012-02-29 | 王莲芬 | Traditional Chinese medicine for treating leucoderma |
| CN104056021A (en) * | 2014-07-11 | 2014-09-24 | 李淑娟 | Traditional Chinese medicine for treating leucoderma |
| CN106038939A (en) * | 2016-07-25 | 2016-10-26 | 陈凯 | Traditional Chinese medicine for treating leukoderma |
-
1999
- 1999-05-14 CN CN 99107327 patent/CN1273847A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100352479C (en) * | 2004-12-29 | 2007-12-05 | 韩石蕊 | Medicament for treating leucoderma and prepartion method |
| CN101204518B (en) * | 2007-12-13 | 2011-06-29 | 孙瑞龙 | Peroral Chinese traditional medicine for blood deficiency cutaneouspruritus |
| CN101361890B (en) * | 2008-09-28 | 2011-07-27 | 中国人民解放军第四军医大学 | Traditional Chinese medicine formulation for treating radioactivity skin impairment |
| CN102362950A (en) * | 2011-06-15 | 2012-02-29 | 王莲芬 | Traditional Chinese medicine for treating leucoderma |
| CN104056021A (en) * | 2014-07-11 | 2014-09-24 | 李淑娟 | Traditional Chinese medicine for treating leucoderma |
| CN106038939A (en) * | 2016-07-25 | 2016-10-26 | 陈凯 | Traditional Chinese medicine for treating leukoderma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327569B (en) | Preparation method and application method of drug and herbal medicine thereof for curing chronic hepatitis B | |
| CN1047946C (en) | Preparation for treating senile diseases | |
| CN100589838C (en) | Acne treating Chinese herbal medicine preparation | |
| CN103083505A (en) | Liver-soothing and qi-regulating traditional Chinese medicine composition used for treating depression, and preparation method thereof | |
| CN101129588A (en) | Medicinal granules for conjunctivitis | |
| CN103212021A (en) | Traditional Chinese medicine composition used for treating chloasma | |
| CN1273847A (en) | Chinese medicine for treating dermatopathy | |
| CN101961386A (en) | Traditional Chinese medicine for treating diabetic skin pruritus | |
| CN101664508B (en) | Drug combination for treating centrality serous chorioretinitis | |
| CN109248305A (en) | A kind of Chinese medicine composition and preparation method thereof for treating liver fibrosis | |
| CN1456206A (en) | Qi-blood tonifying capsule | |
| CN108057077A (en) | Treat Chinese medicine composition of diabete peripheral herve pathology and preparation method thereof | |
| CN1036315C (en) | Leukoderma pill | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN1176113A (en) | Compound bufonin of bufo gargarizans | |
| CN1060379C (en) | Chines medicine for treating vitiligo and preparation method thereof | |
| CN104958662A (en) | Traditional Chinese medicinal composition for treating fatty liver hepatitis and hyperlipemia and preparation method thereof | |
| CN101433685A (en) | Medicament for treating icteric hepatitis and preparation method thereof | |
| CN1149095C (en) | Chinese medicine for treating baby's congenital heart disease | |
| CN103341108B (en) | Pharmaceutical composite for treating stress urinary incontinence after prostatectomy | |
| CN103920005A (en) | Preoperative intervention medicine for general anesthesia of neurosurgery | |
| CN103301372B (en) | Preparation method of umbilicus dressing agent for treating post-operation prostate stress urinary incontinence | |
| CN1426779A (en) | Chinese medicine raw material in form of particles and its preparation method | |
| CN105497783A (en) | Application of traditional Chinese medicine preparation to preparing drug for treating qi stagnation and blood stasis type chloasma | |
| CN1189330A (en) | External-use Chinese herbs liquid and compounding agent for regenerating hair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |